Roxana Daneshjou

Most-cited papers

1. Genome Analysis

   G. Fernald, E. Capriotti, Roxana Daneshjou, K. Karczewski +1 more

   2011Bioinform.6,262 citations Open access

   Semantic Scholar

   Save

2. Data-Driven Prediction of Drug Effects and Interactions

   Nicholas P. Tatonetti, Patrick Ye, Roxana Daneshjou, R. Altman

   2012Science Translational Medicine930 citations Open access

   Semantic Scholar

   Save

3. Bioinformatics challenges for personalized medicine

   G. Fernald, E. Capriotti, Roxana Daneshjou, K. Karczewski +1 more

   2011Bioinform.272 citations Open access

   Semantic Scholar

   Save

4. Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study

   M. Perera, L. Cavallari, N. Limdi, E. Gamazon +38 more

   2013The Lancet254 citations Open access

   Semantic Scholar

   Save

5. Chapter 7: Pharmacogenomics

   K. Karczewski, Roxana Daneshjou, R. Altman

   2012PLoS Comput. Biol.58 citations Open access

   Semantic Scholar

   Save

6. Pathway analysis of genome-wide data improves warfarin dose prediction

   Roxana Daneshjou, Nicholas P. Tatonetti, K. Karczewski, H. Sagreiya +13 more

   2013BMC Genomics45 citations Open access

   Semantic Scholar

   Save

7. Genotype-Guided Dosing of Vitamin K Antagonists

   Roxana Daneshjou, Teri E. Klein, R. Altman

   2014New England Journal of Medicine34 citations Open access

   Semantic Scholar

   Save

8. Pharmacogenomics and big genomic data: from lab to clinic and back again.

   A. Lavertu, G. McInnes, Roxana Daneshjou, M. Whirl-Carrillo +2 more

   2018Human Molecular Genetics29 citations Open access

   Semantic Scholar

   Save

9. PharmGKB summary: very important pharmacogene information for CYP4F2

   Maria L. Alvarellos, K. Sangkuhl, Roxana Daneshjou, M. Whirl-Carrillo +2 more

   2015Pharmacogenetics & Genomics26 citations Open access

   Semantic Scholar

   Save

10. Cohort-specific imputation of gene expression improves prediction of warfarin dose for African Americans

    Assaf Gottlieb, Roxana Daneshjou, Marianne K. DeGorter, Stephane Bourgeois +5 more

    2017Genome Medicine19 citations Open access

    Semantic Scholar

    Save

11. PATH-SCAN: A REPORTING TOOL FOR IDENTIFYING CLINICALLY ACTIONABLE VARIANTS

    Roxana Daneshjou, Z. Zappala, Kim Kukurba, S. Boyle +6 more

    2013Pacific Symposium on Biocomputing14 citations Open access

    Semantic Scholar

    Save

12. Predicting venous thromboembolism risk from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges

    G. McInnes, Roxana Daneshjou, Panagiostis Katsonis, O. Lichtarge +18 more

    2019Human Mutation13 citations Open access

    Semantic Scholar

    Save

13. Population‐specific single‐nucleotide polymorphism confers increased risk of venous thromboembolism in African Americans

    Roxana Daneshjou, L. Cavallari, P. Weeke, K. Karczewski +10 more

    2016Molecular Genetics & Genomic Medicine9 citations Open access

    Semantic Scholar

    Save

14. Pharmacogenomics in Dermatology: Tools for understanding gene-drug associations

    Roxana Daneshjou, R. Huddart, T. Klein, R. Altman

    2019Seminars in cutaneous medicine and surgery3 citations Open access

    Semantic Scholar

    Save

15. Expression Quantitative Trait Loci Analysis of Stable Warfarin Dose Identifies Novel Associations : Finding Signal within the Noise

    E. Gamazon, Roxana Daneshjou, L. Cavallari, N. Limdi +9 more

    20130 citations

    Semantic Scholar

    Save

16. Pathway analysis of genome-wide data improves warfarin dose prediction

    Roxana Daneshjou, Nicholas P. Tatonetti, K. Karczewski, H. Sagreiya +13 more

    2013BMC Genomics0 citations Open access

    Semantic Scholar

    Save